CV Sciences (CVSI) Net Margin Growth (3y) (2016 - 2026)
CV Sciences (CVSI) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15,806.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 3,232.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -987.00 |
| 10 | CV Sciences | - | - | 1.56 Mn | -15,769.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,769.00 |
| Dec 31, 2025 | 7,124.00 |
| Sep 30, 2025 | 1,575.00 |
| Jun 30, 2025 | 7,914.00 |
| Mar 31, 2025 | 3,105.00 |
| Dec 31, 2024 | 15,955.00 |
| Sep 30, 2024 | -1,101.00 |
| Jun 30, 2024 | 5,407.00 |
| Mar 31, 2024 | 4,886.00 |
| Dec 31, 2023 | 15,590.00 |
| Sep 30, 2023 | 4,581.00 |
| Jun 30, 2023 | 5,427.00 |
| Mar 31, 2023 | 19,986.00 |
| Dec 31, 2022 | 1,189.00 |
| Sep 30, 2022 | -1,345.00 |
| Jun 30, 2022 | -9,364.00 |
| Mar 31, 2022 | 2,887.00 |
| Dec 31, 2021 | -19,864.00 |
| Sep 30, 2021 | -2,501.00 |
| Jun 30, 2021 | -9,464.00 |